Structural Heart Devices Market Size Report 2032 | DelveInsight

DelveInsight's Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Market Drivers, barriers, trends, and key Renal Denervation Devices Companies in the market.

To read more about the latest highlights related to the Structural Heart Devices Market, get a snapshot of the key highlights entailed in the Market Report @ Structural Heart Devices Market Size- https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Structural Heart Devices Market Report
• The Structural Heart Devices Market was valued at USD 11,752.22 million in 2024, growing at a CAGR of 10.08% during the forecast period from 2025 to 2032 to reach USD 25,264.95 million by 2032.
• North America is projected to hold the largest share of the structural heart devices market in 2024, driven by several key factors
• The leading Structural Heart Devices Companies such as Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

To know more about why North America is leading the market growth in the Structural Heart Devices Market, get a snapshot @ Structural Heart Devices Market Outlook- https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Structural Heart Devices Market Dynamics
According to BLISS UK (2024), over 13 million preterm births occurred globally each year, with the highest prevalence seen in sub-Saharan Africa and Southern Asia. In the United Kingdom alone, approximately 58,000 premature births were reported annually. In Australia, data from Northern Health Australia (2023) showed that one in every 12 babies is born prematurely, with the rate rising to 15% among Aboriginal babies, resulting in over 26,000 preterm births each year. Preterm birth is a leading cause of structural heart defects in newborns, which increases the demand for structural heart devices used to close holes in the heart associated with congenital heart defects, thereby driving market growth.

Structural Heart Devices Market Segment Analysis
Structural Heart Devices Market by Product Type (Repair Devices [Occluders, Annuloplasty Devices, Valvuloplasty Devices, and Others] and Replacement Devices [Mechanical Heart Valves and Tissue Heart Valves]), Application (Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Structural Heart Devices Market Dynamics @ Structural Heart Devices Market Dynamics Analysis- https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Structural Heart Devices Companies
Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

Structural Heart Devices Market Drivers
The demand for structural heart devices is primarily driven by the rising incidence of structural heart diseases, including heart valve disorders, congenital heart defects, and other related conditions. In addition, the increasing preference for minimally invasive procedures and the surge in product development and launch activities by leading market players are key factors expected to drive the positive growth of the structural heart devices market during the forecast period from 2025 to 2032.

Structural Heart Devices Market Insights
According to data from the Centers for Disease Control and Prevention (CDC, 2025), heart defects affected nearly 1% of all births in the U.S., impacting approximately 40,000 babies each year. Among these, about 1 in 4 infants is born with a critical congenital heart defect requiring intervention. Additionally, CDC data from 2024 highlights that around 1 in every 33 babies, or approximately 120,000 infants annually, are born with congenital anomalies, including structural heart defects. Therefore, the rising incidence of both congenital and acquired heart defects has significantly increased the demand for structural heart devices, which play a vital role in repairing conditions such as septal defects, valve malformations, and other anatomical abnormalities.

Which MedTech key players in the Structural Heart Devices Market are set to emerge as the trendsetter explore @ Structural Heart Devices Companies- https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Structural Heart Devices Market Report
• Coverage- Global
• Forecast Period- 2025-2032
• Structural Heart Devices Companies- Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc, Abbott, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc, Biomerics, Lepu Medical Technology (Beijing) Co. Ltd, Livanova plc, Comed B.V., TORAY INDUSTRIES INC, Occlutech International AB, Microport Scientific Corporation and others.

Interested in knowing the Structural Heart Devices Market by 2032? Click to get a snapshot of the Structural Heart Devices Market Trends- https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

This release was published on openPR.